2021Exhibitor List
Keyword Search

E-Da Health Group

In this exhibition by E-Da Hospital, we will present our achievements of cell therapy. We established GTP-rated Cell Processing Labs and produced CIK cell. In the future, we will focus on ADSC, iPSC and CAT-T cells. Our displays also include autologous chondrocyte cell sheet transplantation therapy for knee joint cartilage defects, autologous fibroblast cells micro-sheet therapy, and esophageal cell sheet repair. Moreover, we will demonstrate the development of Smart Parmacy. Bariartric surgery is also one of foci of this exhibition. We will promote personalized consultation on site. All spectators are welcomed to visit us for consultation. We also expect to establish collaboration with academic and industrial partners.


Medical insole

E-Sun Technology Co., Ltd.

E-Sun Biochemistry Technology Co., Ltd. had founded on July 1st, 1996. E-Sun imported the air purifier from USA in the begining and had started to develop self brand (E-Sun) professtional air purifier for Taiwan market since 2002. There has several series which for medical, commercial and residencial demand. The medical series air purifier had GMP certification by Taiwan FDA. All the series air purifier had also had the BSMI certification. E-Sun had been a leading brand of professional air purifier in Taiwan now.

EBM Technologies

Extending from the original RIS system, Hualien Tsu Chi Hospital has worked with EBM Technologies on building a medical-grade remote supporting environment through the implementation of mobile applications and artificial intelligence (AI) introduced by their own AI center. The remote supporting environment automatically matches the RIS’s worklist with AI-annotated patient images from the PACS and prioritize it based on the level of severity. The AI-based RIS system is intended to enhance medical professionals’ daily reporting workflow, save time, and improve work efficiency.

While medical professionals are working from home, traveling, or on a business trip, the unfinished reports and the images can also be downloaded to AgileRIS, an iOS-based reporting application, and UDE, an iOS-based medical imaging display application. The applications, which are both developed by EBM Technologies, not only allow offline access to work, but also provide medical professionals with a remote reporting experience just like they’re in the hospital.

EirGenix, Inc.

EirGenix believes that health should be advocated for all people. As one of Taiwan’s top biopharmaceutical companies, EirGenix continues to unwaveringly stand by this principle as it provides services aiding clients in creating biosimilars and new drugs, along with manufacturing its own biologics that improve and save lives. With Taiwan’s best in its team, EirGenix offers a customer-focused and transparent experience through its contract development and manufacturing operations (CDMO) unit, where it collaborates with clients to actualise their biologics. Alongside its CDMO unit, the company applies its industry expertise in developing in-house products through its product development and operations unit. Other products and services offered by EirGenix include cell line development, antibody drug conjugates, cGMP-approved production for microbial and mammalian systems, Covid-19 rapid antigen tests, and more. The company continues to develop medical marvels such as carrier proteins for vaccinations and antibody products that treat late-stage cancer. We strive to be a highly reliable source for our clients, but what's most important is to consider the health of the whole world, says Dr Liu-Lee-cheng, founder, president and CEO. EirGenix is a fast-growing biopharmaceutical company. We aim to lead Asia's biopharmaceutical manufacturing and development industries, but beyond that, I envision EirGenix becoming an international biopharmaceutical leader. Demonstrating its tenacity to go global, EirGenix was certified in 2017 by the Ministry of Health, Labour and Welfare of Japan as a foreign manufacturer of biologics, and its facility was approved by Japan’s Pharmaceutical and Medical Device Agency in 2020. The company is now applying for a Biologic License Application from the US FDA. EirGenix is open to CDMO collaborations and joint ventures with industry leaders. It is also keen to connect with investors, mergers and research and development facilities as it builds its biotechnology infrastructure to provide unrivalled patient services worldwide.

En Chu Kong Hospital



Zhou Bo instrument
air filter

Energy Resources International Co. HsinChu Branch

Energy Resources International Co., Ltd (ERI) is a technology pioneer in X-ray radiography field. ERI chose to enter the medical equipment industry and has since been dedicated to delving into the properties and application of Carbon Nanotube material. Through years of experiments, ERI has successfully developed CNT-driven Cold Cathode X-ray emission source. With this technology breakthrough, ERI has moved to rollout the cutting edge battery-powered handheld X-ray devices to revolutionize the dental industry, this dental device is certified by TFDA in early 2021 . ERI is now going on the path in developing portable X-ray systems for extremities and chest screening purpose, CVXair is expected to be launched on Q1 2022.


The RETINA is a stereotactic surgery navigation system for Neurosurgery, Craniofacial, E.N.T., Plastic Surgery, Oral and Maxillofacial Surgery and other types of minimally invasive surgical applications.

The RETINA combines intelligent medical technologies and services which can integrate digital medical imaging for better surgical accuracy. It is compatible with many instruments already used in the OR, which have become a perfect complement while working during surgery. The RETINA also reduces unnecessary tissue injuries, to aid in minimally invasive surgeries, improve surgical quality, and reduce the risk of surgical complications, which provide overall better medical service for patients.

EPROB Robotic Arm + AI is an advanced surgical system that performs robotic-assisted minimally invasive surgery. The robotic arm is controlled through precise coordinates and parameters processed through a navigation system where surgeons have full manageability of the instruments required in various types of brain surgeries.

EPROB Robotic Arm + AI is an innovation in which the surgeon, guided by its experience, performs minimally invasive procedures better and faster by reducing human-related errors which could cause complications. The system delivers highly magnified and 3D high-definition views of the surgical area, allowing surgeons to guide instruments through a single small incision during surgery.